BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 18096137)

  • 1. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Sacco KA; Weinberger AH; Dudas MM; Allen TM; Creeden CL; Potenza MN; Feingold A; Jatlow PI
    Biol Psychiatry; 2008 Jun; 63(11):1092-6. PubMed ID: 18096137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
    Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bupropion smoking cessation clinical trial for cancer patients.
    Schnoll RA; Martinez E; Tatum KL; Weber DM; Kuzla N; Glass M; Ridge JA; Langer C; Miyamoto C; Wileyto EP; Leone F
    Cancer Causes Control; 2010 Jun; 21(6):811-20. PubMed ID: 20087643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes from an outpatient smoking-cessation clinic.
    Roth MT; Andrus MR; Westman EC
    Pharmacotherapy; 2005 Feb; 25(2):279-88. PubMed ID: 15767242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
    Jorenby DE; Leischow SJ; Nides MA; Rennard SI; Johnston JA; Hughes AR; Smith SS; Muramoto ML; Daughton DM; Doan K; Fiore MC; Baker TB
    N Engl J Med; 1999 Mar; 340(9):685-91. PubMed ID: 10053177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.
    Kalman D; Herz L; Monti P; Kahler CW; Mooney M; Rodrigues S; O'Connor K
    Drug Alcohol Depend; 2011 Nov; 118(2-3):111-8. PubMed ID: 21507585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
    Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV
    Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial.
    Mooney ME; Schmitz JM; Allen S; Grabowski J; Pentel P; Oliver A; Hatsukami DK
    Clin Pharmacol Ther; 2016 Oct; 100(4):344-52. PubMed ID: 27213949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for smoking cessation among people with schizophrenia spectrum disorders: a systematic review, meta-analysis, and network meta-analysis.
    Siskind DJ; Wu BT; Wong TT; Firth J; Kisely S
    Lancet Psychiatry; 2020 Sep; 7(9):762-774. PubMed ID: 32828166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion: a review of its use in the management of smoking cessation.
    Holm KJ; Spencer CM
    Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.
    Ebbert JO; Hatsukami DK; Croghan IT; Schroeder DR; Allen SS; Hays JT; Hurt RD
    JAMA; 2014 Jan; 311(2):155-63. PubMed ID: 24399554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
    Jamerson BD; Nides M; Jorenby DE; Donahue R; Garrett P; Johnston JA; Fiore MC; Rennard SI; Leischow SJ
    Clin Ther; 2001 May; 23(5):744-52. PubMed ID: 11394732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial.
    Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE
    Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
    Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
    JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
    Cahill K; Stevens S; Perera R; Lancaster T
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.